Categories
Aurobindo Pharma Limited — Updates, 16-05-2026: General Updates
16-05-2026 · 09:50 am
Aurobindo Pharma's subsidiary CuraTeQ Biologics received market approval for Bevqolva®, a bevacizumab biosimilar. This allows manufacturing and marketing of the drug in India for metastatic carcinoma, marking a key business development.
No comments yet. Be the first to comment!